Kensington Capital Partners has sold Walker Glass Company to Ironbridge Equity Partners
Kensington Capital Partners has sold Walker Glass Company Ltd. to Ironbridge Equity Partners.
Walker Glass, based in Montreal, Canada, is a leading manufacturer of acid-etched glass substrates, premium quality mirrors and bird-friendly glazing solutions. With a legacy dating back to 1942, Walker Glass is uniquely positioned within the glass market as a value-added processor of raw materials, which are treated in-house through proprietary processes, primarily serving glass fabricators.
Ironbridge Equity Partners is a Toronto-based private equity firm with more than US$515 million of assets under management focused exclusively on investing in companies in the Canadian lower middle-market.
Kensington Capital Partners was a minority investor in Walker Glass and is an employee-owned alternative investment firm with US$2.6 billion in assets under management.
Oaklins TM Capital in the US served as the exclusive financial advisor to Walker Glass Company Ltd., a portfolio company of Kensington Capital Partners, in its sale to Ironbridge Equity Partners.



Lee Harrison
President, Walker Glass Company Ltd.
Talk to the deal team
Jerome S. Romano
Oaklins TM Capital
Bradley S. Goldstein
Oaklins TM Capital
Related deals
STM Environmental has been acquired by Phenna Group
STM Environmental has been acquired by Phenna Group, gaining access to a broader network of expertise, enhanced resources and global reach. With extensive experience in life safety, environmental compliance and quality testing, along with a wide client base, Phenna Group is the ideal partner to accelerate STM Environmental’s expansion.
Learn moreDen Berk Délice accelerates growth through strategic partnership
Den Berk Délice, a leading Belgian grower of specialty tomatoes, has entered a strategic partnership with Egeria, an independent investment firm, to realize its next growth phase.
Learn moreXiel Limited has been acquired by MIS Healthcare
MIS Healthcare, a leading distributor in medical imaging, has successfully acquired Xiel Limited. This strategic acquisition merges MIS Healthcare’s extensive radiotherapy portfolio with Xiel’s specialized expertise in nuclear medicine, radiotherapy and diagnostic radiology. The merger strengthens both companies’ positions in the rapidly growing fields of oncology and nuclear medicine, promising to deliver exceptional value to the healthcare community in the UK and Ireland.
Learn more